Meet India’s women Warren Buffetts. And their latest SmallCap bets

In a male dominated space that the stock market investment community is, a few women investors are making big moves and carving a niche for them, with strong returns and picks backed by some solid research. Here are the top picks of 2 such Women Warren Buffetts of India.

It should not come as a surprise to anyone when it is said that the Indian stock market, is a male-dominated space. With names like Rakesh Jhunjhunwala and Radhakishan Damani frequently dominating headlines.

However, if one slightly deviates from the mainstream media, they will learn about a powerful, and often overlooked, force: the astute investment acumen of women. A cohort of women  investors that is quietly amassing significant wealth and influence, demonstrating a keen understanding of market dynamics and a knack for identifying lucrative opportunities. These women, which we dub “India’s Women Warren Buffetts,” are not merely following trends; they are setting them.

Their strategies, though diverse, share a common thread: a focus on long-term value, rigorous research, and an unwavering commitment to their investment philosophies. Unlike the often-flashy, high-risk approach sometimes associated with day trading, these investors demonstrate patience and discipline, carefully selecting companies with strong fundamentals and sustainable growth potential. They are not chasing quick gains; they are building lasting legacies.

Let us look at 2 of such women Warren Buffetts and their latest big bets… Sangeetha S – Patspin India Ltd (PIL)

Sangeetha S noted investor known for her diverse and strategic stock selections, making her a respected figure in the financial markets. Sangeetha’s investment strategy emphasizes long-term growth and diversification across various sectors. 

This approach helps mitigate risks and capitalize on opportunities, ensuring sustained portfolio growth and resilience against market volatility.

As per trendlyle.com, she currently holds 111 stocks with a net worth of Rs 566 cr.

Sangeetha has bought a 3.9% stake worth Rs 1.6 cr in Patspin India Ltd as per exchange filings made for the quarter ending December 2024.

PIL with a market cap of Rs 41 cr, manufactures and exports of cotton yarn in medium, fine and superfine combed yarns. The company has reduced its overall debt by 60% in the last 5 years from Rs 181 cr to Rs 73 cr.

What is surprising is that this stake at PIL by Sangeetha comes in at a time when the financials for the company look shaky.

 » Read More

Related Articles

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain

Range bound session: Nifty ends above 23,600, Sensex holds 78,000 led by Adani Ports, Infosys

The stock markets faced a downturn on Thursday, with major indices closing in the red. The BSE Sensex dropped by 213.12 points or 0.27%, ending the day at 78,058.16, while the NSE Nifty 50 saw a decline of 70.15 points, down by 0.3%, and closed at 23,626.15. The Nifty Bank index also ended the day

IT stocks stable as Cognizant raises annual and quarterly revenue guidance

Shares of Indian IT companies are in the spotlight today after the Nasdaq-listed IT services major Cognizant Technology Solutions, reported its Q4 results that exceeded Wall Street expectations. The Nifty IT Index as well as individual tech counters like Infosys, Wipro, Tech Mahindra and HCL Tech are all in the green even as the markets